Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?
Jie Hua,1–4,* Si Shi,1–4,* Dingkong Liang,1–4 Chen Liang,1–4 Qingcai Meng,1–4 Bo Zhang,1–4 Quanxing Ni,1–4 Jin Xu,1–4 Xianjun Yu1–4 1Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, S...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-08-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/current-status-and-dilemma-of-second-line-treatment-in-advanced-pancre-peer-reviewed-article-OTT |